Inhaling Penehyclidine to Prevent Perioperative Respiratory Adverse Events in Children at Risk Undergoing Sevoflurane Anesthesia

PHASE4RecruitingINTERVENTIONAL
Enrollment

204

Participants

Timeline

Start Date

November 12, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2026

Conditions
Respiratory HypersensitivityPerioperative Respiratory Adverse EventsAnticholinergicsInhalation Therapy; ComplicationsHigh Risk
Interventions
DRUG

Penehyclidine hydrochloride

The penehyclidine hydrochloride will be diluted to a total volume of 5 mL with normal saline, added to the nebulizer cup for inhalation. Patients will be asked to inhale the entire volume of nebulized drugs within 30 min prior to surgery. The trial drugs will be administered using a jet nebulizer with compressed air flow. Each child will be intructed to begin the nebulization by using a face mask that covers the nose and mouth while the child is seated upright. Children will be encouraged to take deep and slow breaths, inhaling through the mouth and exhaling through the nose, to ensure the drugs effectively reaches the airway.

DRUG

Normal Saline

The normal saline with a total volume of 5 mL will be added to the nebulizer cup for inhalation. Patients will be asked to inhale the entire volume of nebulized drugs within 30 min prior to surgery. The trial drugs will be administered using a jet nebulizer with compressed air flow. Each child will be intructed to begin the nebulization by using a face mask that covers the nose and mouth while the child is seated upright. Children will be encouraged to take deep and slow breaths, inhaling through the mouth and exhaling through the nose, to ensure the drugs effectively reaches the airway.

Trial Locations (2)

510060

RECRUITING

Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou

518040

NOT_YET_RECRUITING

Shenzhen Eye Hospital, Shenzhen

All Listed Sponsors
collaborator

Shenzhen Eye Hospital

OTHER

lead

Sun Yat-sen University

OTHER

NCT06624696 - Inhaling Penehyclidine to Prevent Perioperative Respiratory Adverse Events in Children at Risk Undergoing Sevoflurane Anesthesia | Biotech Hunter | Biotech Hunter